BR100 Increased By (0.11%)
BR30 Decreased By (-0.26%)
KSE100 Increased By (0.12%)
KSE30 Increased By (0.09%)
AGHA 7.79 Increased By ▲ 0.04 (0.52%)
BECO 5.23 Increased By ▲ 0.04 (0.77%)
BML 57.26 Decreased By ▼ -1.40 (-2.39%)
BOP 34.10 Increased By ▲ 0.41 (1.22%)
CNERGY 9.92 Decreased By ▼ -0.69 (-6.5%)
CSIL 5.35 Increased By ▲ 0.05 (0.94%)
FCCL 54.61 Increased By ▲ 0.87 (1.62%)
FFL 16.70 Increased By ▲ 0.24 (1.46%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.42 Increased By ▲ 0.14 (1.92%)
KOSM 5.75 Increased By ▲ 0.11 (1.95%)
LOTCHEM 29.35 Decreased By ▼ -0.30 (-1.01%)
MLCF 94.35 Decreased By ▼ -2.01 (-2.09%)
NBP 202.70 Decreased By ▼ -0.83 (-0.41%)
NCPL 57.00 Increased By ▲ 0.15 (0.26%)
NPL 67.78 Increased By ▲ 0.47 (0.7%)
OGDC 316.40 Decreased By ▼ -1.82 (-0.57%)
PACE 10.64 Increased By ▲ 0.01 (0.09%)
PAEL 43.15 Increased By ▲ 1.38 (3.3%)
PIBTL 16.72 Decreased By ▼ -0.09 (-0.54%)
PPL 220.50 Increased By ▲ 0.33 (0.15%)
PRL 49.05 No Change ▼ 0.00 (0%)
PTC 70.98 Increased By ▲ 0.97 (1.39%)
SSGC 28.17 Decreased By ▼ -0.97 (-3.33%)
TBL 9.90 Increased By ▲ 0.13 (1.33%)
TELE 8.80 Decreased By ▼ -0.02 (-0.23%)
TPL 18.14 Increased By ▲ 0.97 (5.65%)
TPLP 13.40 Increased By ▲ 0.89 (7.11%)
TREET 22.75 Increased By ▲ 0.16 (0.71%)
TRG 60.30 Increased By ▲ 0.08 (0.13%)
Business & Finance

India to start COVID-19 vaccine exports as soon as Wednesday

  • The first batch of exports will be shipped to the tiny nation of Bhutan, said the officials, who asked not to be named as the plans are not public.
  • India has received requests from dozens of nations, including urgent appeals from Brazil, to begin exports of the vaccine from the SII centre in the western city of Pune.
Published Updated
By

NEW DELHI: India, one of the world's biggest drugmakers, will start exports of COVID-19 vaccines as early as Wednesday, government sources said, paving the way for many mid- and lower-income countries to secure supplies of the easy-to-store Oxford/AstraZeneca vaccine.

The first batch of exports will be shipped to the tiny nation of Bhutan, said the officials, who asked not to be named as the plans are not public.

Two million doses of the vaccine, developed by AstraZeneca and Oxford University and manufactured by Serum Institute of India (SII), will also be despatched to Bangladesh on Thursday, said officials briefed on the plans.

SII, the world's largest maker of vaccines, did not immediately respond to a request for comment.

SII last week told Reuters it soon expected emergency use authorisation from the World Health Organization (WHO) for the Oxford/AstraZeneca shot, which it has been licensed to make for dozens of low- and middle-income countries.

That would pave the way for SII to begin supplies to the WHO-backed COVAX initiative aimed at fairly distributing COVID-19 shots across the world.

The Oxford/AstraZeneca vaccine, which can be stored at refrigerator temperature, is widely viewed as a more viable option for many poorer nations than shots from Pfizer and Moderna that have more onerous cold-storage requirements.

India has received requests from dozens of nations, including urgent appeals from Brazil, to begin exports of the vaccine from the SII centre in the western city of Pune.

Prime Minister Narendra Modi's government, however, wanted to roll out the vaccination drive at home before launching exports, one of the sources said.

India began giving shots of the Oxford/AstraZeneca vaccine, as well as another developed by Bharat Biotech, to health workers on Saturday.

India plans to start exporting Bharat Biotech's vaccine at a later stage.

Another source said landlocked Bhutan would get its Oxford/AstraZeneca shots free. "We will begin from tomorrow, other neighbouring countries will follow soon," the source said.

Sri Lanka, Nepal, Myanmar and the Maldives have all made requests for early delivery of vaccines.

Comments

Comments are closed for this article.